;(1a) R=Me, R'=H, X=O, Y=Z=F; (1b) R=H, R'=Me, X=O, Y=Z=F; (1c) R=Me, R'=H, X=CH2, Y=Z=H; (1d) R=H, R'=Me, X=CH2, Y=Z=H; (1e) R=Me, R'=H, X=CH2, Y=Z=F; (1f) R=H, R'=Me, X=CH2, Y=Z=F. Invention also relates to method of producing of N-(2-aminopurine-6-yl)-6-aminocaproic acid amides of general formula (1). Method involves acylation of corresponding enantiomerically pure chiral heterocyclic amines of general formula , where X, Y, Z, R, and R′ have values given above, with acyl chloride of 6-phthalimidecapronic acid, removal of phthaloyl protective group under action of hydrazine hydrate, nucleophilic substitution of obtained compounds with chlorine atoms in 2-acetamido-6-chloropurine followed by acetyl group alkaline hydrolysis in obtained product.;EFFECT: invention relates to N-(2-aminopurine-6-yl)-6-aminocaproic acid of general formula 1, which have high anticancer activity and low toxicity.;3 cl, 1 tbl, 6 ex"/> AMIDES OF N-(2-AMINOPURIN-6-YL)-6-AMINOCAPROIC ACID, HAVING ANTI-TUMOUR ACTIVITY AND SYNTHESIS METHOD THEREOF
首页> 外国专利> AMIDES OF N-(2-AMINOPURIN-6-YL)-6-AMINOCAPROIC ACID, HAVING ANTI-TUMOUR ACTIVITY AND SYNTHESIS METHOD THEREOF

AMIDES OF N-(2-AMINOPURIN-6-YL)-6-AMINOCAPROIC ACID, HAVING ANTI-TUMOUR ACTIVITY AND SYNTHESIS METHOD THEREOF

机译:具有抗肿瘤活性的N-(2-氨基普林-6-YL)-6-氨基癸酸的酰胺及其合成方法

摘要

FIELD: pharmaceutics.;SUBSTANCE: in general formula 1; ;(1a) R=Me, R'=H, X=O, Y=Z=F; (1b) R=H, R'=Me, X=O, Y=Z=F; (1c) R=Me, R'=H, X=CH2, Y=Z=H; (1d) R=H, R'=Me, X=CH2, Y=Z=H; (1e) R=Me, R'=H, X=CH2, Y=Z=F; (1f) R=H, R'=Me, X=CH2, Y=Z=F. Invention also relates to method of producing of N-(2-aminopurine-6-yl)-6-aminocaproic acid amides of general formula (1). Method involves acylation of corresponding enantiomerically pure chiral heterocyclic amines of general formula , where X, Y, Z, R, and R′ have values given above, with acyl chloride of 6-phthalimidecapronic acid, removal of phthaloyl protective group under action of hydrazine hydrate, nucleophilic substitution of obtained compounds with chlorine atoms in 2-acetamido-6-chloropurine followed by acetyl group alkaline hydrolysis in obtained product.;EFFECT: invention relates to N-(2-aminopurine-6-yl)-6-aminocaproic acid of general formula 1, which have high anticancer activity and low toxicity.;3 cl, 1 tbl, 6 ex
机译:物质:通式1; ;(1a)R = Me,R'= H,X = O,Y = Z = F; (1b)R = H,R'= Me,X = O,Y = Z = F; (1c)R = Me,R'= H,X = CH 2 ,Y = Z = H; (1d)R = H,R'= Me,X = CH 2 ,Y = Z = H; (1e)R = Me,R'= H,X = CH 2 ,Y = Z = F; (1f)R = H,R'= Me,X = CH 2 ,Y = Z = F。本发明还涉及通式(1)的N-(2-氨基嘌呤-6-基)-6-氨基己酸酰胺的生产方法。该方法涉及将通式为<图像文件=“ 00000007.GIF” he =“ 27” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 44” />的相应对映体纯手性杂环胺进行酰化,其中X,Y, Z,R和R'具有上述给出的值,用6-邻苯二甲酰亚胺己酸的酰氯,在水合肼的作用下除去邻苯二甲酰基保护基,用2-乙酰氨基-6-氯嘌呤中的氯原子进行亲核取代,然后所得产物中的乙酰基碱性水解。效果:本发明涉及具有高抗癌活性和低毒性的通式1的N-(2-氨基嘌呤-6-基)-6-氨基己酸; 3cl,1tbl ,6前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号